SAME MEDICATION1
FOR DOGS.
EASIER-TO-SWALLOW PRICE
FOR OWNERS.
A TREAT YOU’LL BOTH ENJOY
Watch how Tri-Heart® Plus protects your pet and saves you money
THE SAME PROVEN ACTIVE INGREDIeNTS
AS THE LEADING HEARTWORM PREVENTATIVE BRAND1
HEARTWORM PREVENTION FOR EVERY SIZE DOG
A simple and palatable monthly, chewable tablet protects by killing the larvae before they reach your dog’s heart.
Small Dogs
1-25 Lbs
Medium Dogs
26-50 Lbs
Large Dogs
51 – 100 Lbs
STOP THE INFECTION CYCLE
A mosquito carrying heartworm larva can infect your dog with worms that develop and reproduce inside him. Treatment for heartworm disease can be long and costly, and is no guarantee a dog will survive.
Once a dog is infected he is also at risk for spreading heartworms to other dogs by infecting new mosquitos. Tri-Heart® Plus keeps your dog safe and helps prevent the spread of infection.
JUST AS EFFECTIVE, JUST AS PALATABLE
94% of dogs enjoy the chewable tablets.3
A taste test of Tri-Heart® Plus Chewable Tablets vs. Heartgard® Plus Chewables showed that dogs have no preference.3
100% SATISFACTION GUARANTEE
If for any reason you are not satisfied, speak to your veterinarian or call our toll-free guarantee center at 1-800-224-5318 for replacement or refund. In the unlikely case of infection arising while on Tri-Heart® Plus our new comprehensive guarantee sheet covers treatment drug costs and veterinary service fees.
More detailsSTART SAVING WITH TRI-HEART® PLUS TODAY
Find a vetImportant Safety Information:
All dogs should be tested for heartworm infection before starting a preventive program. In a small percentage of ivermectin/pyrantel treated dogs, digestive and neurological side effects may occur.
References:
- Tri-Heart® Plus [prescribing information]. Madison, NJ: Merck Animal Health; 2014; Heartgard® Plus [prescribing information]. Duluth, GA: Boehringer Ingelheim; 2019.
- Average discounted price of Tri-Heart® Plus compared to Heartgard® Plus. March 2025.
- September 2000, ANADA 200-338, Palatability of Chewable Tablets. Heska Corporation Submission
HEARTGARD is a registered trademark of Boehringer Ingelheim.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global